| Michele Bahl, LCSW | |
|
1541 Annex Rd, Jefferson, WI 53549-9803 | |
| (920) 674-3105 | |
| (920) 674-6113 |
| Full Name | Michele Bahl |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 24 Years |
| Location | 1541 Annex Rd, Jefferson, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376762682 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 7330-123 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jefferson County | 2264496801 | 14 |
News Archive
Type 1 diabetes is a lifelong disease characterized by high levels of sugar (glucose) in the blood. It is caused by the patient's immune system attacking and destroying the cells in their pancreas that produce the hormone insulin, which regulates blood glucose levels. Surprisingly, little is known about the mechanisms regulating the sensitivity and resistance of these cells, which are known as beta-cells, to immune system attack.
Most of us think of DNA mutations as the culprits that cause cancer. Scott Ness, PhD, University of New Mexico Professor of Molecular Genetics and Microbiology and Associate Director at the UNM Cancer Center, thinks there may be another, more elusive culprit. If Dr. Ness is right his research, funded as part of the National Cancer Institute's Provocative Questions Project, might open a whole new arena in which to target anticancer drugs.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, announced today that the first patient has been enrolled in its Phase II trial of ICT-107 at the New Jersey Neuroscience Institute at JFK Medical Center. ICT-107 is the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM).
A more specific and faster detection of viruses has been identified in new research by Trinity College Dublin's Professor of Physics, Martin Hegner at Trinity College's Centre of Research on Adaptive Nanostructures and Nanodevices (CRANN) and an international team of researchers.
Eyedrops administered to infants as part of routine outpatient retinopathy of prematurity (ROP) screening can have life-threatening consequences. A case report published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) describes cardiopulmonary arrest in a 27-week-old infant following administration of three sets of cyclopentolate 0.2%/phenylephrine 1% (Cyclomydril) eyedrops.
› Verified 8 days ago
| Entity Name | Jefferson County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275614919 PECOS PAC ID: 2264496801 Enrollment ID: O20041115000371 |
News Archive
Type 1 diabetes is a lifelong disease characterized by high levels of sugar (glucose) in the blood. It is caused by the patient's immune system attacking and destroying the cells in their pancreas that produce the hormone insulin, which regulates blood glucose levels. Surprisingly, little is known about the mechanisms regulating the sensitivity and resistance of these cells, which are known as beta-cells, to immune system attack.
Most of us think of DNA mutations as the culprits that cause cancer. Scott Ness, PhD, University of New Mexico Professor of Molecular Genetics and Microbiology and Associate Director at the UNM Cancer Center, thinks there may be another, more elusive culprit. If Dr. Ness is right his research, funded as part of the National Cancer Institute's Provocative Questions Project, might open a whole new arena in which to target anticancer drugs.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, announced today that the first patient has been enrolled in its Phase II trial of ICT-107 at the New Jersey Neuroscience Institute at JFK Medical Center. ICT-107 is the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM).
A more specific and faster detection of viruses has been identified in new research by Trinity College Dublin's Professor of Physics, Martin Hegner at Trinity College's Centre of Research on Adaptive Nanostructures and Nanodevices (CRANN) and an international team of researchers.
Eyedrops administered to infants as part of routine outpatient retinopathy of prematurity (ROP) screening can have life-threatening consequences. A case report published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) describes cardiopulmonary arrest in a 27-week-old infant following administration of three sets of cyclopentolate 0.2%/phenylephrine 1% (Cyclomydril) eyedrops.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michele Bahl, LCSW 1541 Annex Rd, Jefferson, WI 53549-9803 Ph: (920) 674-3105 | Michele Bahl, LCSW 1541 Annex Rd, Jefferson, WI 53549-9803 Ph: (920) 674-3105 |
News Archive
Type 1 diabetes is a lifelong disease characterized by high levels of sugar (glucose) in the blood. It is caused by the patient's immune system attacking and destroying the cells in their pancreas that produce the hormone insulin, which regulates blood glucose levels. Surprisingly, little is known about the mechanisms regulating the sensitivity and resistance of these cells, which are known as beta-cells, to immune system attack.
Most of us think of DNA mutations as the culprits that cause cancer. Scott Ness, PhD, University of New Mexico Professor of Molecular Genetics and Microbiology and Associate Director at the UNM Cancer Center, thinks there may be another, more elusive culprit. If Dr. Ness is right his research, funded as part of the National Cancer Institute's Provocative Questions Project, might open a whole new arena in which to target anticancer drugs.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, announced today that the first patient has been enrolled in its Phase II trial of ICT-107 at the New Jersey Neuroscience Institute at JFK Medical Center. ICT-107 is the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM).
A more specific and faster detection of viruses has been identified in new research by Trinity College Dublin's Professor of Physics, Martin Hegner at Trinity College's Centre of Research on Adaptive Nanostructures and Nanodevices (CRANN) and an international team of researchers.
Eyedrops administered to infants as part of routine outpatient retinopathy of prematurity (ROP) screening can have life-threatening consequences. A case report published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) describes cardiopulmonary arrest in a 27-week-old infant following administration of three sets of cyclopentolate 0.2%/phenylephrine 1% (Cyclomydril) eyedrops.
› Verified 8 days ago
Christine Richards-pagel, MSW, APSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1541 Annex Rd, Jefferson, WI 53549 Phone: 920-674-3105 | |
Ms. Rabecca Catherine Cole, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1541 Annex Rd, Jefferson, WI 53549 Phone: 920-674-3105 Fax: 920-674-6113 | |
Suzanne A Monda, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 104 W Linden Dr Ste A, Jefferson, WI 53549 Phone: 920-674-6688 | |
Ms. Katherine Sue Drechsler, MSW, LCSW-SA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1541 Annex Road, Jefferson, WI 53549 Phone: 920-674-8107 | |
Sara Kay Zwieg, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1541 Annex Rd, Jefferson, WI 53549 Phone: 920-674-3105 | |
Lisa Dunham, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1541 Annex Rd, Jefferson, WI 53549 Phone: 920-674-7424 Fax: 920-674-7409 |